Some of the significant insights from cancer genomics include the identification of driver mutations that are crucial for cancer development. These mutations can occur in genes such as TP53, KRAS, and BRCA1/BRCA2. Additionally, cancer genomics has revealed the concept of tumor heterogeneity, where different cells within the same tumor can have distinct genetic profiles, contributing to treatment resistance and disease progression.
